Tumor Board Review -

Tumor Board Review

Guideline and Case Reviews in Oncology
Buch | Hardcover
382 Seiten
2012
Demos Medical Publishing (Verlag)
978-1-936287-17-8 (ISBN)
99,35 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
Provides comprehensive coverage of various topics in oncology. This title offers an overview of epidemiology and risk factors followed by a sequence of specific presentations organized by tumors stage or disease classification.
Tumor Board Review utilises the knowledge and expertise of oncology specialists to enhance learning the practice of oncology. Each of the 32 chapters follows a uniform format: a concise summary of the epidemiology, risk factors, natural history, and pathology of each major organ-specific tumor type; an abbreviated display of the relevant staging (generally based on the American Joint Commission on Cancer [AJCC] Staging, 7th Edition); and several ""tumor board-style"" illustrative patient case summaries (representative of major stage categories of each tumor), each followed by an evidence-based case discussion which reviews the current guidelines and rationale for the diagnostic and therapeutic steps taken. Algorithms and decision tree graphics are used extensively to provide visual support of the decision process.

The combination of case presentations and evidence-based management discussions make this volume a unique tool for keeping current with clinical guidelines and provides the reader with a clear understanding of applications of new information for use in daily practice. The case presentations and authoritative discussions make Tumor Board Review a valuable resource for board study and self-assessment.

Features of Tumor Board Review Include:

Comprehensive coverage of all areas of oncology
Presentation of most recent guidelines and management standards in concise, user-friendly format
In-depth ""tumor board"" presentations showing clear clinical applications
Special focus on indications and use of new drugs, and treatment of new side effects
Extensive use of algorithms
Colour atlas section of pathology photomicrographs

Robert Todd III, MD, PhD. Chair of Medicine, Baylor College of Medicine |Kathleen Cooney, MD. Chief of Hematology/Oncology, Michigan University School of Medicine |Teresa Hayes, MD, PhD. Assistant Professor of Oncology, Baylor College of Medicine |Martha Pritchett Mims, MD, PhD. Chief of Hematology/Oncology, Baylor College of Medicine |Francis Worden, MD. Clinical Associate Professor of Oncology and Fellowship Director, Michigan University School of Medicine

Head and Neck Cancer, 2. Thyroid Cancer, 3. Non-Small Cell Lung Cancer, 4. Small Cell Lung Cancer, 5. Breast Cancer, 6. Esophageal Cancer, 7. Gastric Cancer, 8. Pancreatic Cancer, 9. Neuroendocrine Cancer, 10. Hepatobiliary Cancers, 11. Colorectal Cancer, 12. Anal Cancer, 13. Prostate Cancer, 14. Testicular Cancer, 15. Kidney Cancer, 16. Bladder Cancer, 17. Cervical Cancer, 18. Uterine Cancer, 19. Ovarian Cancer, 20. Melanoma, 21. Bone Sarcoma. 22. Soft Tissue Sarcoma, 23. Primary Brain Tumors, 24. Cancer of Unknown Primary, 25. Hodgkins Disease, 26. Non-Hodgkins Lymphoma, 27. Multiple Myeloma, 28. Acute Lymphoid Leukemia, 29. Acute Myeloid Leukemia, 30. Chronic Myeloid Leukemia, 31. Chronic Lymphocytic Leukemia, 31. Myelodysplastic Syndrome

Verlagsort New York, NY
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 1-936287-17-X / 193628717X
ISBN-13 978-1-936287-17-8 / 9781936287178
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00

von Stein Husebø; Gebhard Mathis; Eva Katharina Masel

Buch | Softcover (2023)
Springer (Verlag)
49,99